EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Artificial intelligence (AI) and machine learning (ML) in precision oncology: a review on enhancing discoverability through multiomics integration

Lise Wei, Dipesh Niraula, Evan D H Gates, Jie Fu, Yi Luo, Matthew J Nyflot, Stephen R Bowen, Issam M El Naqa, Sunan Cui iD

The British Journal of Radiology · 01.10.2023 · 96 (1150)

DOI: 10.1259/bjr.20230211 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The British Journal of Radiology, online erschienen am 03.09.2023. Verfasst von Lise Wei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Michigan, Michigan, United States. Hauptthemen laut MEDLINE: Artificial Intelligence, Neoplasms. Die Arbeit wurde bisher 169-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiomics data including imaging radiomics and various types of molecular biomarkers have been increasingly investigated for better diagnosis and therapy in the era of precision oncology. Artificial intelligence (AI) including machine learning (ML) and deep learning (DL) techniques combined with the exponential growth of multiomics data may have great potential to revolutionize cancer subtyping, risk stratification, prognostication, prediction and clinical decision-making. In this article, we first present different categories of multiomics data and their roles in diagnosis and therapy. Second, AI-based data fusion methods and modeling methods as well as different validation schemes are illustrated. Third, the applications and examples of multiomics research in oncology are demonstrated. Finally, the challenges regarding the heterogeneity data set, availability of omics data, and validation of the research are discussed. The transition of multiomics research to real clinics still requires consistent efforts in standardizing omics data collection and analysis, building computational infrastructure for data sharing and storing, developing advanced methods to improve data fusion and interpretability, and ultimately, conducting large-scale prospective clinical trials to fill the gap between study findings and clinical benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceNeoplasmsHumansMultiomicsProspective StudiesPrecision MedicineMachine Learning

Autor:innen und Institutionen

  • Department of Radiation Oncology, University of Michigan, Michigan, United States.
  • Department of Radiation Oncology, Moffitt Cancer Center, Tampa, United States.
  • Department of Radiation Oncology, University of Washington, Washington, United States.
  • Department of Radiation Oncology, Stanford University, Stanford, California, United States.

ORCID-Profile: Sunan Cui

Zitieren

APA

Wei, L., Niraula, D., Gates, E. D. H., Fu, J., Luo, Y., Nyflot, M. J., Bowen, S. R., El Naqa, I. M., & Cui, S. (2023). Artificial intelligence (AI) and machine learning (ML) in precision oncology: a review on enhancing discoverability through multiomics integration. The British Journal of Radiology, 96(1150). https://doi.org/10.1259/bjr.20230211

Vancouver

Wei L, Niraula D, Gates EDH, Fu J, Luo Y, Nyflot MJ, et al. Artificial intelligence (AI) and machine learning (ML) in precision oncology: a review on enhancing discoverability through multiomics integration. The British Journal of Radiology. 2023;96(1150). doi:10.1259/bjr.20230211

BibTeX
@article{Wei2023,
  author = {Wei, Lise and Niraula, Dipesh and Gates, Evan D H and Fu, Jie and Luo, Yi and Nyflot, Matthew J and Bowen, Stephen R and El Naqa, Issam M and Cui, Sunan},
  title = {Artificial intelligence (AI) and machine learning (ML) in precision oncology: a review on enhancing discoverability through multiomics integration},
  journal = {The British Journal of Radiology},
  year = {2023},
  volume = {96},
  number = {1150},
  doi = {10.1259/bjr.20230211}
}
Kostenlos starten →